Compare · head to head
Lexicon Pharmaceuticals vs Xeris Pharmaceuticals
Xeris Pharmaceuticals ranks higher overall — 360 rank 70 vs 28.
Xeris Pharmaceuticals leads on Quality (69 vs 43) and Growth (76 vs 45). Lexicon Pharmaceuticals leads on Sentiment (57 vs 52). The two are close on Safety.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | Small | Small |
| ISIN | US5288723027 | US98422E1038 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 28 | 70 |
| Value | NR | 39 |
| Quality | 43 | 69 |
| Growth | 45 | 76 |
| Safety | 32 | 35 |
| Sentiment | 57 | 52 |
| Quality details | ||
| Profitability | 35 | 65 |
| Cash Truth | NR | 72 |
Lexicon Pharmaceuticals vs MannKindLexicon Pharmaceuticals vs Kura OncologyLexicon Pharmaceuticals vs Kestra Medical TechnologiesAdd a third stock →
Full analyses: Lexicon Pharmaceuticals · Xeris Pharmaceuticals
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100